{
    "clinical_study": {
        "@rank": "158188", 
        "acronym": "ORBITA", 
        "arm_group": [
            {
                "arm_group_label": "Coronary angioplasty", 
                "arm_group_type": "Active Comparator", 
                "description": "Percutaneous coronary intervention and optimal medical therapy"
            }, 
            {
                "arm_group_label": "Optimal medical therapy", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo percutaneous coronary intervention and optimal medical therapy with risk factor modification and anti-anginal therapy"
            }
        ], 
        "brief_summary": {
            "textblock": "In this study the investigators will use careful scientific blinding of patient and their\n      subsequent healthcare staff so that the investigators can determine exactly how much\n      difference coronary angioplasty makes to symptoms and blood supply to the heart. After the 6\n      weeks blinded phase, all patients will be unblinded and the patients who had undergone sham\n      procedure will be offered the active therapy."
        }, 
        "brief_title": "Comparison of Coronary Angioplasty and Optimum Medical Therapy Versus Optimal Medical Therapy in the Stable Angina", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Stable Angina", 
        "condition_browse": {
            "mesh_term": [
                "Angina Pectoris", 
                "Coronary Artery Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "The investigators will perform a multi-centre prospective randomised double-blinded\n      comparison of the treatment of stable angina with percutaneous coronary intervention (PCI)\n      and optimal medical therapy (OMT) versus a sham procedure and OMT. Three hundred patients\n      with stable angina and one or more angiographically significant coronary stenosis of 70% or\n      more in a single vessel that is suitable for angioplasty will be recruited. Baseline\n      investigation of functional capacity and myocardial ischaemic burden will be performed. This\n      will be followed by a coronary angiogram and invasive physiological  investigation followed\n      by randomisation to PCI or a sham procedure. Follow-up investigation of functional capacity\n      and myocardial ischaemic burden at 6 weeks will then be performed."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Stable angina and at least 1 lesion with angiographic stenosis \u226570% in a single\n             vessel suitable for stent implantation\n\n        Exclusion Criteria:\n\n          -  Acute coronary syndrome\n\n          -  Previous coronary artery bypass graft surgery\n\n          -  Left main stem disease\n\n          -  Contraindications to PCI or drug-eluting stent (DES) implantation\n\n          -  Heavily calcified or tortuous vessels\n\n          -  Chronic total occlusion in target vessel\n\n          -  Life expectancy <2yr\n\n          -  Pregnancy\n\n          -  Age <18yr or >85yr\n\n          -  Angiographic stenosis \u2265 50% in non-target vessel\n\n          -  Inability to consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 31, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02062593", 
            "org_study_id": "ORBITA-1"
        }, 
        "intervention": {
            "arm_group_label": [
                "Coronary angioplasty", 
                "Optimal medical therapy"
            ], 
            "description": "Percutaneous coronary intervention with drug-eluting stents and modern techniques", 
            "intervention_name": "Coronary angioplasty", 
            "intervention_type": "Procedure", 
            "other_name": "Percutaneous coronary intervention"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Stable angina", 
            "Percutaneous coronary intervention", 
            "Optimal medical therapy"
        ], 
        "lastchanged_date": "March 25, 2014", 
        "link": {
            "description": "Transcatheter Cardiovascular Therapeutics 2013 Study outline presentation", 
            "url": "http://www.tctmd.com/show.aspx?id=121398"
        }, 
        "location": [
            {
                "contact": {
                    "email": "kare.tang@btuh.nhs.uk", 
                    "last_name": "Kare Tang, FRCP"
                }, 
                "facility": {
                    "address": {
                        "city": "Basildon", 
                        "country": "United Kingdom", 
                        "zip": "SS16 5NL"
                    }, 
                    "name": "Basildon and Thurrock University Hospitals NHS Trust"
                }, 
                "investigator": [
                    {
                        "last_name": "Kare Tang, FRCP", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "John Davies, MRCP PhD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "andrewsharp@doctors.org.uk", 
                    "last_name": "Andrew Sharp, MRCP MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Exeter", 
                        "country": "United Kingdom", 
                        "zip": "EX2 5DW"
                    }, 
                    "name": "Royal Devon & Exeter Foundation Trust"
                }, 
                "investigator": {
                    "last_name": "Andrew Sharp, MRCP MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "r.al-lamee13@imperial.ac.uk", 
                    "last_name": "Rasha Al-Lamee, MRCP"
                }, 
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Imperial College Healthcare NHS Trust"
                }, 
                "investigator": {
                    "last_name": "Justin E Davies, MRCP PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "Defining a Gold Standard for Ischaemia: Effects of Interventional Revascularisation Versus Optimum Medical Therapy on Exercise Capacity in Patients With Stable Coronary Artery Disease", 
        "overall_contact": {
            "email": "r.al-lamee13@imperial.ac.uk", 
            "last_name": "Rasha Al-Lamee"
        }, 
        "overall_official": [
            {
                "affiliation": "Imperial College London", 
                "last_name": "Justin E Davies, MRCP, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Imperial College London", 
                "last_name": "Darrel P Francis, MRCP, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Imperial College London", 
                "last_name": "Rasha K Al-Lamee, MRCP", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Research Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Exercise time on treadmill", 
            "safety_issue": "No", 
            "time_frame": "6 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02062593"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Imperial College London", 
        "sponsors": {
            "collaborator": {
                "agency": "Volcano Corporation", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Imperial College London", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}